Show simple item record

We Underdose Antibiotics in Patients on CRRT

dc.contributor.authorShaw, Alexander R.
dc.contributor.authorChaijamorn, Weerachai
dc.contributor.authorMueller, Bruce A.
dc.date.accessioned2016-07-06T18:21:12Z
dc.date.available2017-09-06T14:20:19Zen
dc.date.issued2016-07
dc.identifier.citationShaw, Alexander R.; Chaijamorn, Weerachai; Mueller, Bruce A. (2016). "We Underdose Antibiotics in Patients on CRRT." Seminars in Dialysis 29(4): 278-280.
dc.identifier.issn0894-0959
dc.identifier.issn1525-139X
dc.identifier.urihttps://hdl.handle.net/2027.42/122407
dc.description.abstractAppropriate antibiotic dosing in critically ill, infected, patients receiving continuous renal replacement therapy (CRRT) is crucial to improve patient outcomes. Severe sepsis and septic shock result in changes in pharmacokinetic parameters, including increased volume of distribution, hypoalbuminemia, and changes in renal and nonrenal clearances. The lack of CRRT standardization, nonrecognition of how CRRT variability affects antibiotic removal, fear of antibiotic toxicity, and limited drug dosing resources all contribute to suboptimal antibiotic therapy. Even when antibiotic CRRT pharmacokinetic studies are available, they are often based on old CRRT methodologies that do not exist in contemporary CRRT practice, resulting in unhelpful/inaccurate dosing recommendations. Application of these older doses in Monte Carlo simulation studies reveals that many of the recommended dosing regimens will never attain pharmacodynamic targets. In this review, using cefepime as an example, we illustrate whether clinicians are likely to achieve pharmacokinetic/pharmacodynamic targets when the recommended dosing regimens are prescribed in this patient population. We encourage clinicians to aggressively dose antibiotics with large loading dose and higher maintenance doses to reach the targets.
dc.publisherClinical and Laboratory Standards Institute
dc.publisherWiley Periodicals, Inc.
dc.titleWe Underdose Antibiotics in Patients on CRRT
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/122407/1/sdi12496_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/122407/2/sdi12496.pdf
dc.identifier.doi10.1111/sdi.12496
dc.identifier.sourceSeminars in Dialysis
dc.identifier.citedreferenceLewis SJ, Mueller BA: Antibiotic dosing in patients with kidney injury: “enough but not too much”. J Intensive Care Med 31: 164 – 176, 2016
dc.identifier.citedreferenceUchino S, Kellum J, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813 – 818, 2005
dc.identifier.citedreferenceCLSI: Performance Standards for Antimicrobial Susceptibility Testing; Twenty‐Fourth Informational Supplement. CLSI document M100‐S24. Wayne, PA: Clinical and Laboratory Standards Institute, 2014
dc.identifier.citedreferenceChaijamorn W, Jitsurong A, Wiwattanawongsa K, Wanakamanee U, Dandecha P: Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Int J Antimicrob Agents 38: 152 – 156, 2011
dc.identifier.citedreferenceRoberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, et al.: Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 40: 1523 – 1528, 2012
dc.identifier.citedreferenceScoville BA, Mueller BA: Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy. Am J Kidney Dis 61: 490 – 500, 2013
dc.identifier.citedreferenceKidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2: 1 – 138, 2012
dc.identifier.citedreferenceLegrand M, Darmon M, Joannidis M, Payen D: Management of renal replacement therapy in ICU patients: an international survey. Intensive Care Med 39: 101 – 108, 2013
dc.identifier.citedreferenceSeyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent JL, et al.: Recommended β ‐lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 15: R137, 2011
dc.identifier.citedreferenceLewis SJ, Mueller BA: Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent. Semin Dial 27: 441 – 445, 2014
dc.identifier.citedreferenceKollef MF, Sherman G, Ward S, Fraser VJ: Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115: 462 – 474, 1999
dc.identifier.citedreferenceLi AM, Gomersall CD, Choi G, Tian Q, Joynt GM, Lipman J: A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data? J Antimicrob Chemother 64: 929 – 937, 2009
dc.identifier.citedreferenceFinfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, et al.: Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the Saline versus Albumin Fluid Evaluation (SAFE) study. BMJ 333: 1044, 2006
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.